Overview

Evaluation of Liposomal Curcumin in Healthy Volunteers

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Aim of the present study is: - To evaluate the safety and tolerability of increasing doses of intravenous liposomal Curcumin in healthy subjects by means of adverse events, vital signs and safety laboratory assessments. - To investigate the pharmacokinetics of increasing doses of intravenous liposomal Curcumin in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
SignPath Pharma, Inc.
Treatments:
Curcumin